• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing

Charles River Labs Soars to a New High and More Strength Is Coming

CRL has been in a strong technical trend for some time now.
By BRUCE KAMICH
Feb 12, 2020 | 10:30 AM EST
Stocks quotes in this article: CRL

In his second "Executive Decision" segment of Mad Money Tuesday evening, Jim Cramer checked in with Jim Foster, chairman, president and CEO of Charles River Laboratories Int'l. (CRL) , a stock that's up 37% over the past 12 months, including 9.8% Tuesday on strong earnings.

Foster explained that drug and biotech companies are growing like weeds and need laboratory services to help them bring new drugs to market faster. Charles River helps take a full year off of drug development time, saving billions of dollars.

When asked about China, Foster said that Charles River has a research facility in China and is helping to educate the Chinese on the research-led model that is working so well in the U.S. Let's check and see how the charts of CRL are working.

In this daily bar chart of CRL, below, we can see that the prices were in a strong condition before Tuesday's upside price gap. CRL was trading above the rising 50-day moving average line and above the rising 200-day moving average line. A bullish golden cross of the 50-day and 200-day averages can be seen in December.

The daily On-Balance-Volume (OBV) line has risen the past 12 months even as prices traded sideways from June to early November. The Moving Average Convergence Divergence (MACD) oscillator turned bullish in November and remains positive.

In this weekly bar chart of CRL, below, we can see that prices have nearly doubled in the past three years. Prices are firmly above the rising 40-week moving average line.

The weekly OBV line just made a new high for the move up to confirm and support the uptrend in price. The MACD oscillator is bullish and making its own new high for the move up.

In this daily Point and Figure chart of CRL, below, we can see Tuesday's price rally without the price gap. A potential upside price objective of $226 is being indicated.

Bottom line strategy: CRL has been in a strong technical trend for some time now. New highs just confirms the strength. Stay long or go long on a dip towards $173-$172 and risk a close below $165. The $226 area is our price target.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Earnings | Investing | Stocks | Technical Analysis | Trading | Healthcare | Pharmaceuticals | Technology | Mad Money | Executive Interview

More from Investing

The Bears Just Moved Into Wall Street

James "Rev Shark" DePorre
Sep 22, 2023 4:26 PM EDT

Technically, the bears are in control of this market now.

3 Overlooked Mid-Cap Stocks With High Dividend Yields

Bob Ciura
Sep 22, 2023 3:00 PM EDT

There are strong dividend stocks in this 'middle' category worthy of consideration for income investors.

Don't Be a Sap and Step Into a Value Trap

Bret Jensen
Sep 22, 2023 12:30 PM EDT

There are plenty of stocks that look like value plays but aren't as the market continues to drag more share prices down.

My Stock Pick for the Rest of 2023? The Big 'B'

Stephen Guilfoyle
Sep 22, 2023 11:17 AM EDT

Here's why I'm going with a diversified value name.

IBM Knocks on the Door of Its 52-Week High, But Nobody Answers

Bruce Kamich
Sep 22, 2023 10:45 AM EDT

Let's drill down to see the risk/reward conditions of the stock and why it may no longer be a 'Best Idea.'

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:20 PM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    Trading in Multiple Time Frames
  • 10:24 AM EDT BRUCE KAMICH

    This Could Get Messy

    A number of key stocks are getting close to import...
  • 01:41 PM EDT CHRIS VERSACE

    Latest AAP Podcast With Helene Meisler!

    Listen in as the Action Alerts PLUS podcast talks ...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login